Recognizing obesity as a chronic disease can improve treatment, address complications, and reshape healthcare strategies for ...
Allowing such medications as options could lead to significant savings from improved health, writes Kelley Koch.
A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!
Right now, our state’s most vulnerable populations that rely on Medicare and Medicaid are unable to access anti-obesity ...
Researchers found that high fructose intake, especially from processed foods, is linked to metabolic dysfunction-associated ...
Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.
Scientists mapped fat tissue differences in obese individuals, uncovering cell changes linked to metabolic disease risk and ...
Cardiovascular diseases claim more lives in the U.S. than all forms of cancer and accidental deaths combined, according to ...
Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...
Keeping kids healthy can be a big job. From the day their children are born, parents ferry them to and from medical offices, ...
Recent reports reveal heart disease is the leading cause of death in the U.S., many of whom are younger than 45. Here's what ...
Loneliness and social isolation have been linked to an elevated risk of non-alcoholic fatty liver disease (NAFLD), according ...